Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
NCT06906640
Chronic Disease, Chronic Kidney Disease(CKD)
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT06719050
This study will be conducted from enrollment until the end of the six-month follow-up period.
This study aims to assess the impact of the Internet hospital online + offline integrated chronic disease management model on patients with type 2 diabetes mellitus. It will also evaluate the economic impact of the model and identify the characteristics of the appropriate population for the model. Finally, it will develop a toolkit to help manage chronic diseases.
The study will include 1,636 patients with type 2 diabetes who did not reach the standard of control target of glucose, blood pressure or LDL at the endocrine outpatient clinic and inpatient wards of the Third Hospital of Peking University. We will collect information from participants before the study starts. And the patients will be followed up for 6 months from enrollment. The study management mode included online and offline integrated management in the Internet hospital, and routine offline management mode. After completing the enrollment and assessment, we will arrange outpatient follow-up and management according to the current status, doctor's requirements, and study subjects' needs.
Trial opening soon.
Get NotifiedHealthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at 6±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 3±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Time frame: at 6±1 month from the enrollment
Contact information is provided by the study sponsor or research team.
Zeng Lin, Ph. D.
Other
Application and Evaluation of Telehealth-Based Chronic Disease Management for Type 2 Diabetes
Acronym: T2DMTH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06906640
Chronic Disease, Chronic Kidney Disease(CKD)
Birmingham, Alabama, United States
View Trial DetailsNCT06906627
Chronic Disease, Chronic Kidney Disease(CKD)
Birmingham, Alabama, United States
View Trial DetailsNCT06862739
Behavior, Diabetes Mellitus
Faisalabad, Punjab Province, Pakistan
View Trial DetailsNCT06954090
Albuminuria, Female Urogenital Diseases
Herlev, Hajdú-Bihar, Denmark
View Trial Details